Home and Away star Johnny Ruffo shares heartbreaking update on his terminal cancer diagnosis
Johnny Ruffo continues his battle with terminal brain cancer.
The former Home and Away star, 34, started another round of chemotherapy this week.
He posted a picture on Wednesday of himself undergoing hospital treatment with his girlfriend Tahnee Sims by his side.
The actor put on a very brave face, smiled and gave thumbs up while sitting in a chair.
“Back in my favorite chair,” he wrote sarcastically alongside the hashtags #ihatethischair and #f**kcancer.
Sad: Former Home and Away star Johnny Ruffo continues his battle with terminal brain cancer. He began another round of chemotherapy before the new year and posted a photo of himself in hospital on Wednesday
TV star: The actor is best known for his role of Chris Harrington in the Seven Soap from 2013 to 2016 (pictured)
Johnny’s close friends and Home and Away co-stars praised the singer for his strength.
“Sending you so much love Johnny,” Emily Symons remarked.
“Big love to you mate, big love,” Georgie Parker added.
“I think of you Johnny, I have followed your struggle. Keep fighting,” one fan wrote.
‘You are an inspiration Johnny! Australia loves you,” added another.
Tough time: Johnny’s longtime girlfriend Tahnee also shared a photo of Johnny reclining in the hospital chair
Meanwhile, model Samantha Harris wrote, “We’ve only met you a few times, but you really are one of those people who can always light up a room.”
Johnny’s longtime friend Tahnee also shared a photo of Johnny reclining in the hospital chair.
In December, the actor and singer marked another year in which he underwent chemotherapy and revealed he was looking forward to taking a break and spending time with family over Christmas.
Concerns: In August 2022, Johnny confirmed his brain cancer diagnosis was terminal and said he feared how his girlfriend Tahnee would cope once he is gone
Johnny was first diagnosed with brain cancer in 2017 after going to the hospital with painful migraines
Scary: In August of that year, he had emergency surgery and a 7 cm brain tumor was surgically removed from his frontal lobe, before undergoing chemotherapy and radiotherapy
Progression: Johnny went into remission months after his initial diagnosis in 2017, but revealed in November 2021 that the disease had returned
‘Another year of chemotherapy behind us. It wasn’t easy, but I made it,” he wrote at the time.
‘I can’t wait to take a few weeks off over Christmas and spend some well deserved time with my family. #f**kcancer.’
In August 2022, Johnny confirmed his brain cancer diagnosis was terminal and said he fears how his girlfriend Tahnee would cope once he is gone.
“You can only imagine how hard it’s been for her,” he said on The Project.
“What’s on my mind a lot is, I hate saying this, no matter how hard it can be for her if something happens to me.
“So it’s something I don’t want to think about. It just makes me a little emotional because I know something will happen at some point, whether it’s, you know, in a month or 10 years or 20 years from now.”
Johnny told then-host Carrie Bickmore that he had already outlived his life expectancy.
“At some point it will get to me, but I’m still fighting. Still kicking. When I look up my diagnosis and my tumor, the average life expectancy was three years,” he said.
Johnny was first diagnosed with brain cancer in 2017 after going to the hospital with painful migraines.
Tragedy: The former Dancing with the Stars contestant revealed in August that his prognosis was terminal
In August of that year, he had emergency surgery and a 7cm brain tumor was surgically removed from his frontal lobe before undergoing chemotherapy and radiotherapy.
The former X Factor star went on to praise his partner Tahnee, calling her his ‘guardian angel’.
“She’s here with every step I take,” he said. “I’m so incredibly grateful to have her by my side, I don’t know what I would do without her.”
Johnny went into remission months after his initial diagnosis in 2017, but revealed in November 2021 that the disease had returned.